Standard BioTools (STU:FLB) Total Liabilities : €184.3 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Standard BioTools Total Liabilities?

Standard BioTools's Total Liabilities for the quarter that ended in Mar. 2024 was €184.3 Mil.

Standard BioTools's quarterly Total Liabilities declined from Sep. 2023 (€441.33 Mil) to Dec. 2023 (€432.02 Mil) and declined from Dec. 2023 (€432.02 Mil) to Mar. 2024 (€184.32 Mil).

Standard BioTools's annual Total Liabilities increased from Dec. 2021 (€159.85 Mil) to Dec. 2022 (€445.36 Mil) but then declined from Dec. 2022 (€445.36 Mil) to Dec. 2023 (€432.02 Mil).

Standard BioTools Total Liabilities Historical Data

The historical data trend for Standard BioTools's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard BioTools Total Liabilities Chart

Standard BioTools Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

100.08

152.65

159.85

445.36

432.02

Standard BioTools Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															437.87	433.09	441.33	432.02	184.32

Standard BioTools Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Standard BioTools's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	100.253	+	(31.505	+	286.396
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	13.861	+	0)
	=	432.0

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	296.252	-	-135.763
	=	432.0

Standard BioTools's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	111.83	+	(28.894	+	2.595
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	41.004	+	0)
	=	184.3

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	715.454	-	531.131
	=	184.3

Standard BioTools Total Liabilities Related Terms

Thank you for viewing the detailed overview of Standard BioTools's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Standard BioTools (STU:FLB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Standard BioTools Inc (STU:FLB) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

LAB:USA FLB:Germany

Address

2 Tower Place, Suite 2000, South San Francisco, CA, USA, 94080

Website

https://www.standardbio.com

Standard BioTools Inc manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. The company's segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Standard BioTools (STU:FLB) Headlines

No Headlines